Immuneering Corporation United States of America (USA)

Research

Date range: 1 December 2020 - 30 November 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Immuneering Corporation published between 1 December 2020 - 30 November 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Immuneering Corporation
Count Share
4 0.07

Outputs by subject (Share)

Outputs by subject
Subject Count Share
3 0.03
1 0.04
1 0.04

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.19 0.17 0.00 0.00 0.10

Compare Immuneering Corporation with other institutions

Collaboration

Date range: 1 December 2020 - 30 November 2021

International vs. domestic collaboration by Share

  • 46.23% Domestic
  • 53.77% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Immuneering Corporation by Share (54 total)

  1. Immuneering Corporation and U.S. Food and Drug Administration (USFDA) (0.35)
    Immuneering Corporation0.06
    U.S. Food and Drug Administration (USFDA)0.28
  2. Immuneering Corporation and National Institutes of Health (NIH) (0.25)
    Immuneering Corporation0.02
    National Institutes of Health (NIH)0.22
  3. Immuneering Corporation and Cornell University (0.15)
    Immuneering Corporation0.06
    Cornell University0.08
  4. Immuneering Corporation and Q2 Solutions (0.12)
    Immuneering Corporation0.06
    Q2 Solutions0.06
  5. Immuneering Corporation and Illumina, Inc. (0.10)
    Immuneering Corporation0.02
    Illumina, Inc.0.08
  6. Immuneering Corporation and SAS Institute Inc. (0.10)
    Immuneering Corporation0.05
    SAS Institute Inc.0.05
  7. Immuneering Corporation and Frederick National Laboratory for Cancer Research (FNLCR) (0.09)
    Immuneering Corporation0.01
    Frederick National Laboratory for Cancer Research (FNLCR)0.08
  8. Immuneering Corporation and Mount Sinai Health System (MSHS) (0.08)
    Immuneering Corporation0.02
    Mount Sinai Health System (MSHS)0.06
  9. Immuneering Corporation and ResearchDx, Inc. (0.07)
    Immuneering Corporation0.01
    ResearchDx, Inc.0.06
  10. Immuneering Corporation and Cancer Genetics, Inc. (CGI) (0.07)
    Immuneering Corporation0.01
    Cancer Genetics, Inc. (CGI)0.06

Top 10 international collaborators with Immuneering Corporation by Share (73 total)

  1. Immuneering Corporation and University of Toronto (U of T) (0.51)
    Immuneering Corporation0.04
    University of Toronto (U of T)0.47
  2. Immuneering Corporation and F. Hoffmann-La Roche AG (0.36)
    Immuneering Corporation0.06
    F. Hoffmann-La Roche AG0.29
  3. Immuneering Corporation and Korea University (0.11)
    Immuneering Corporation0.01
    Korea University0.10
  4. Immuneering Corporation and Academia Sinica (0.09)
    Immuneering Corporation0.01
    Academia Sinica0.08
  5. Immuneering Corporation and University of Oxford (0.08)
    Immuneering Corporation0.04
    University of Oxford0.04
  6. Immuneering Corporation and Virgen del Rocío University Hospital (0.08)
    Immuneering Corporation0.04
    Virgen del Rocío University Hospital0.04
  7. Immuneering Corporation and Bruno Kessler Foundation (FBK) (0.08)
    Immuneering Corporation0.04
    Bruno Kessler Foundation (FBK)0.04
  8. Immuneering Corporation and Fudan University (0.08)
    Immuneering Corporation0.02
    Fudan University0.05
  9. Immuneering Corporation and EATRIS ERIC- European Infrastructure for Translational Medicine (0.08)
    Immuneering Corporation0.02
    EATRIS ERIC- European Infrastructure for Translational Medicine0.05
  10. Immuneering Corporation and Institute for Molecular Medicine Finland (FIMM) (0.07)
    Immuneering Corporation0.03
    Institute for Molecular Medicine Finland (FIMM)0.04